NIH-funded research R01 grant

Understanding genetic causes of intellectual disability across diverse populations

Official title: Elucidating the Genetic Etiology of Intellectual Disability in African, Asian, and European Families

Funded at Columbia University Health Sciences · NIH-11397280 · Data updated 2026-11-12

Aiming to find gene variants that contribute to intellectual disability in people from African, Asian, and European backgrounds to improve diagnosis and future treatments.

More Disability research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionColumbia University Health Sciences
NIH-funded
Lab location1 site (New York, United States)
Project startAugust 14, 2023
Project endJuly 31, 2028
Funding year2026
Award (this year)$657,616
NIH project number5R01HD109342-04
Project IDNIH-11397280 on NIH RePORTER

Who could benefit from this research

Could help

Individuals or families with intellectual disability from the specified populations who can provide DNA samples and family member data.

Less likely to help

People without intellectual disability or from populations not included in the study may not directly benefit.

What this research studies

This project will study families affected by intellectual disability from Finland, Hungary, Mali, and Pakistan, using trio and extended-family DNA samples to identify genetic variants. Researchers will perform next-generation sequencing on affected individuals and parents, then analyze the data with in-house tools to pinpoint candidate variants. Validated variants will be checked for how they segregate with the condition in families, helping connect genes to ID across diverse populations.

Why it matters

Potential benefit: If successful, the work could lead to better genetic screening and understanding of how ID develops, potentially guiding future therapies.

How similar studies have gone: Previous studies have identified many ID genes, but many remain undiscovered, especially in non-European populations, making this approach important and moderately novel.

Where this research is happening

  • Columbia University Health Sciences
    New York, United States
    Active

Researchers

  • Principal investigator: Leal, Suzanne M — Columbia University Health Sciences
  • Study coordinator: Leal, Suzanne M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.